Ignite Creation Date:
2024-05-06 @ 3:23 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04615663
Status:
UNKNOWN
Last Update Posted:
2020-11-04
First Post:
2020-06-16
Brief Title:
Assessment of Burden Disease in Patients With Mast Cell Disorders
Sponsor:
University Hospital Toulouse
Organization:
University Hospital Toulouse
Study Overview
Official Title:
Assessment of Personal Psychosocial Work and Economic Burden in Patients With Mast Cell Disorders
Status:
UNKNOWN
Status Verified Date:
2020-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MCDBuDi
Brief Summary:
The symptoms caused by mast cell disorders can have a significant impact on the state of health of individuals constituting a real burden for them and consequently altering their quality of life It therefore seems important to clarify the impact on the quality of life on the psycho-affective sphere on professional life and on the direct and indirect costs caused by the disease as well as on the patients remaining burden It seems possible by a longitudinal study patient follow-up over 1 year
Primary objective is Assessment of quality of life in adult patient with mast cell diseases at M0
Primary objective is Assessment of quality of life in adult patient with mast cell diseases at M0
Detailed Description:
Mast cell activation symptoms are due to the release of mast cell mediators after uncontrolled activation of mast cells The release by mast cells of mast cell mediators tryptase histamine prostaglandins serotonin results in mast cell activation symptoms found in mast cell activation syndrome but also in mastocytosis These symptoms interested the skin gastrointestinal gut pulmonary cardiovascular and neuropsychiatric organs etc
In mastocytosis along with these symptoms of mast cell activation the infiltration of different organs by abnormal mast cells produces many clinical signs related to the excess of monoclonal mast cells present in the organs
According to our clinical experience the impact of mast cell disorder on various dimensions of life including economic life seems important but it has never accurately evaluated
In mastocytosis along with these symptoms of mast cell activation the infiltration of different organs by abnormal mast cells produces many clinical signs related to the excess of monoclonal mast cells present in the organs
According to our clinical experience the impact of mast cell disorder on various dimensions of life including economic life seems important but it has never accurately evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None